Home > News > The next frontier in inward investment: corporate R&D
January 16th, 2008
The next frontier in inward investment: corporate R&D
Abstract:
IBM, Microsoft, Pfizer, Genzyme, Warwick Effect Polymers, Boston Scientific, Medtronic, Eli Lilly, Merck Sharpe & Dohme, Intel, Alcatel-Lucent, GlaxoSmithKline, and Roche are among the overseas firms collaborating in the newly funded research projects, which are exploring areas ranging from digital signal processing, nanotechnology, photonics, and materials science to biomaterials, drug delivery, solid state pharmaceuticals research, reproductive biology and immunology.
Source:
bulletin.sciencebusiness.net
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Optically trapped quantum droplets of light can bind together to form macroscopic complexes March 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Researchers develop artificial building blocks of life March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
'Sudden death' of quantum fluctuations defies current theories of superconductivity: Study challenges the conventional wisdom of superconducting quantum transitions January 12th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||